https://novapharmanews.com/companies/cansino-biologics/projects/recombinant-trivalent-poliomyelitis-vaccine-sf-r-poliomyelitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/camurus-ab/projects/hs-19-647 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn8022-4392 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn00808-09 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn00808-08 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/14341 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/inactivated-types-1-2-and-3-poliovirus-d-antigen-poliomyelitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4v-mc-jahw 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv44749-ba-10196 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/snoxa12c401 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ly03010-ct-eur-102 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/can-201-ndg 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1850-hpp-303 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/aa-hpp-407 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/sp-mh20vyx 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-302 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-98854-ats3019 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bc45538 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/debio-4126-301 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst191-05 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/hutchmed-europe-b-v/projects/2018-523-00us1 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1i-mc-gzbp 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i8f-mc-gpix 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpeh 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-oxi-2017-18 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/angelo 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep-005 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dbp-053-01 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/131i-tlx-101-003 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2420-acro-201 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-54828-302 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-18424-309 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-7859 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-7749 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9536-7752 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/iovance-biotherapeutics-inc/projects/iov-com-202 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nc2022-01 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/kailera-therapeutics/projects/k9531-3107 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/333-301 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-308 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-303 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-212 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-205 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/ivosidenib-venetoclax-azacitidine-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/sp-chloroquine-amodiaquine-primaquine-artesunate-malaria 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/sinobioway-cell-therapy-co/projects/the-chimeric-antigen-receptor-t-cell-immunothera-lymphoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd/projects/mcv-acyw135-vaccine-group-meningitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/shanghai-mental-health-center/projects/phase-1-olanzapine-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/simvastatin-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cytarabine-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/botulinum-toxin-type-a-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/atorvastatin-vitiligo 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/glofitamab-mcl 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/inactivated-poliomyelitis-vaccine-imovax-poliomyelitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/methoxy-polyethylene-glycol-epoetin-beta-mircera-anemia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/epoetin-beta-neorecormon-anemia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/telbivudine-hepatitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/coagulation-factor-viia-recombinant-hemophilia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/xanomeline-and-trospium-chloride-capsules-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/alkermes-pharma-ireland/projects/alks-9072-low-dose-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/avapritinib-gist 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/paliperidone-palmitate-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/lenvatinib-osteosarcoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/poliorix-poliomyelitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/fluticasone-furoate-rhinitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/photonamic-gmbh-co-kg/projects/gl-01 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-l19tnftmz-01-20 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/rofe-iii-24-1 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/e-s-g-i-s 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn00808-05 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/sunshine-biopharma/projects/tpo-itp 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/venetoclax-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/ursodeoxycholic-acid-combined-with-total-glucosi-hepatitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/tislelizumab-hnscc 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/dexamethasone-itp 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/decitabine-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/cytarabine-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/actinium-pharmaceuticals/projects/cytarabine-phase-1-only-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/cumberland-pharmaceuticals-inc/projects/intravenous-ibuprofen-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/open-label-selinexor-thymoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/inhibikase-therapeutics/projects/imatinib-mesylate-cml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/vanda-pharmaceuticals/projects/iloperidone-crystalline-formulation-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/aquestive-therapeutics/projects/riluzole-oral-soluble-film-als 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/rigel-pharmaceuticals-inc/projects/fostamatinib-lymphoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/linperlisib-combination-with-obinutuzumab-lymphoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/apatinib-thyroid 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/solid-biosciences/projects/bevacizumab-irinotecan-glioblastoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/design-therapeutics/projects/topotecan-usual-sclc 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/bridgebio-oncology-therapeutics/projects/infigratinib-is-provided-as-a-single-dose-of-min-achondroplasia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/bridgebio-oncology-therapeutics/projects/infigratinib-glioma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/bridgebio-oncology-therapeutics/projects/infigratinib-achondroplasia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/bridgebio-oncology-therapeutics/projects/acoramidis-amyloidosis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/naltrexone-hydrochloride-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/minocycline-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/kura-oncology/projects/ziftomenib-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/adaptive-biotechnologies-corp/projects/bendamustine-lymphoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/ultragenyx-pharmaceutical/projects/triheptanoin-als 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/crinetics-pharmaceuticals/projects/paltusotine-acromegaly 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/amneal-pharmaceuticals/projects/asenapine-sublingual-tablets-10-mg-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/rhythm-pharmaceuticals-inc/projects/setmelanotide-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/xyrem-sodium-oxybate-oral-solution-fibromyalgia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/sodium-oxybate-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/sodium-oxybate-fibromyalgia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/defibrotide-dlbcl 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ferric-carboxymaltose-anemia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/erenumab-fibromyalgia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/coartem-artemether-lumefantrine-combination-malaria 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/calcium-gluconate-trauma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/amodiaquine-plus-artesunate-co-administration-malaria 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-fibromyalgia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/spd489-lisdexamfetamine-dimesylate-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/peginesatide-anemia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ixazomib-glioblastoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-and-hydrochlorothiazide-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-lymphoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ziv-aflibercept-lymphoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/agios-pharmaceuticals-inc/projects/mitapivat-anemia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/acadia-pharmaceuticals-inc/projects/pimavanserin-34-milligrams-mg-nuplazid-schizophrenia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/acadia-pharmaceuticals-inc/projects/active-drug-pimavanserin-17mg-2-strength-tablets-parkinson-disease 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/aripiprazole-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/aripiprazole-im-depot-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/roxadustat-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/placebo-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/recombinant-oncolytic-herpes-simplex-virus-type-osteosarcoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/paliperidone-er-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/eloralintide-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/mutual-support-group-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/evolocumab-dyslipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/parsaclisib-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/lanreotide-autogel-120-mg-acromegaly 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/infanrix-hexa-poliomyelitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/chloroquine-malaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e7090-cholangiocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/apellis-pharmaceuticals/projects/pegcetacoplan-c3g 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/apellis-pharmaceuticals/projects/pegcetacoplan-pnh 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/akebia-therapeutics/projects/vadadustat-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/patisiran-amyloidosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nok0024-z2023097 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/clinuvel-europe-limited/projects/cuv105 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-l19tnflom-01-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2227-btg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190184 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vanda-pharmaceuticals/projects/tradipitant-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/ultragenyx-pharmaceutical/projects/sirolimus-lymphangioleiomyomatosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/ultragenyx-pharmaceutical/projects/melphalan-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/nektar-therapeutics/projects/nivolumab-ependymoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/indivior-pharmaceuticals/projects/risperidone-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/indivior-pharmaceuticals/projects/perseris-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/umbralisib-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/corcept-therapeutics-inc/projects/mifepristone-300-mg-korlym-hypercortisolism 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/vosoritide-hypochondroplasia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/vosoritide-achondroplasia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/aprea-therapeutics/projects/apr-548-azacitidine-mds 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/xyrem-fibromyalgia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/valbenazine-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/semaglutide-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/semaglutide-cardiomyopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/rituximab-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/inhaled-treprostinil-sarcoidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/dinutuximab-ganglioneuroblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/asparaginase-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/al-coartem-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/sonrotoclax-cll 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/roflumilast-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ramelteon-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/pramlintide-metreleptin-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/pioglitazone-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/clarithromycin-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/cumberland-pharmaceuticals-inc/projects/acetadote-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/tirzepatide-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-dyslipidemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/acadia-pharmaceuticals-inc/projects/pimavanserin-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/solid-biosciences/projects/filgrastim-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/lorcaserin-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/dronabinol-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/clozapine-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/adaptive-biotechnologies-corp/projects/temozolomide-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/abatacept-dermatomyositis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/risperidone-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/trilaciclib-osteosarcoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/selinexor-thymoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/selinexor-liposarcoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/selinexor-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vanda-pharmaceuticals/projects/vhx-896-and-iloperidone-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/ani-pharmaceuticals-inc/projects/yutiq-0-18-mg-drug-implant-uveitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/selinexor-amyloid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vanda-pharmaceuticals/projects/iloperidone-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/puma-biotechnology-inc/projects/temozolomide-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/levamisole-anemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/ibrutinib-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/acetazolamide-levamisole-hcc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/varenicline-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/aprea-therapeutics/projects/apr-246-azacitidine-mds 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/gt-biopharma/projects/temozolomide-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/active-bmn-111-subcutaneous-injection-of-recomme-achondroplasia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/ivosidenib-venetoclax-gilteritinib-selinexor-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/gt-biopharma/projects/surgical-tumor-resection-gammatile-radiation-the-glioblastoma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/iron-sucrose-human-erythropoietin-injection-vita-anemia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/poliovirus-vaccine-poliomyelitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/oral-supplementation-of-vitamin-d-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/iron-isomaltoside-injection-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/inactivated-poliomyelitis-vaccine-sabin-strains-poliomyelitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/carbon-nanoparticle-iron-suspension-for-injectio-hnscc 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/berberine-plus-lifestyle-intervention-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/cellectar-biosciences/projects/i-131-clr1404-injection-glioma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/cardiff-oncology/projects/oct-amd 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/autologous-anti-bcma-chimeric-antigen-receptor-t-itp 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/68ga-fapi-biotin-tumor 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/iron-and-zinc-combined-anemia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/dna-vaccine-prime-malaria 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-fat-transfer-wound 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/talampanel-als 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/sabin-based-inactivated-poliomyelitis-vaccine-si-poliomyelitis 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/phentermine-obesity 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/iguratimod-itp 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/tscan-therapeutics/projects/soc-tsc-100-aml 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/skin-stretching-device-ssd-trauma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/68ga-fap-chx-tumor 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/cullinan-therapeutics/projects/cln-978-sle 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/amylyx-pharmaceuticals/projects/amx0114-als 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/amylyx-pharmaceuticals/projects/amx0035-als 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/ultragenyx-pharmaceutical/projects/heme-arginate-porphyria 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/nektar-therapeutics/projects/nktr-102-q14d-tumor 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/nektar-therapeutics/projects/nktr-102-100-mg-m2-tumor 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/dordaviprone-onc201-glioma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/dordaviprone-onc201-glioblastoma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cold-stored-platelets-csp-trauma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/biospecimen-collection-glioma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oral-cep-701-myeloma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/iparomlimab-and-tuvonralimab-injection-ql1706-cholangiocarcinoma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/glyt-1-inhibitor-1-schizophrenia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/a-compound-glutamine-capsule-mucositis 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/a-compound-glutamine-capsule-a-compound-glutamin-mucositis 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/gt-biopharma/projects/stereotactic-radiation-therapy-glioblastoma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/rani-therapeutics-holdings/projects/rt-114-is-the-ranipill-capsule-with-pg-102-for-t-obesity 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/anti-cd19-car-nk-nhl 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/tonix-pharmaceuticals-holding/projects/tnx-102-sl-tablet-5-6-mg-fibromyalgia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/tonix-pharmaceuticals-holding/projects/tnx-102-sl-tablet-2-8mg-fibromyalgia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/tonix-pharmaceuticals-holding/projects/tnx-102-sl-tablet-2-8-mg-fibromyalgia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/tislelizumab-combined-with-chemoradiotherapy-escc 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/recombinant-human-erythropoietin-lymphoma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/preoperative-lanreotide-treatment-acromegaly 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/induction-chemotherapy-and-immunotherapy-escc 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/68ga-pentixafor-lymphoma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/aclaris-therapeutics/projects/ati-50002-topical-solution-vitiligo 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/bridgebio-oncology-therapeutics/projects/infigratinib-0-25-mg-kg-day-achondroplasia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/bridgebio-oncology-therapeutics/projects/infigratinib-0-128-mg-kg-day-hypochondroplasia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/bridgebio-oncology-therapeutics/projects/infigratinib-0-016-mg-kg-achondroplasia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/lb-pharmaceuticals-inc/projects/lb-102-50-mg-tablet-schizophrenia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/vaccine-pvcs-n-c-r-malaria 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/rimonabant-schizophrenia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/meningococcal-groups-a-and-c-and-haemophilus-b-c-meningitis 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/theravance-biopharma/projects/td-9855-group-1-fibromyalgia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/maplight-therapeutics/projects/placebo-schizophrenia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/biocryst-pharmaceuticals-inc/projects/forodesine-hydrochloride-lymphoma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/structure-therapeutics/projects/aleniglipron-or-placebo-obesity 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-inc/projects/ataluren-aniridia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/rhythm-pharmaceuticals-inc/projects/placebo-obesity 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/bmn-111-administration-via-injector-pen-achondroplasia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/axsome-therapeutics/projects/axs-14-esreboxetine-fibromyalgia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/summit-therapeutics/projects/ivonescimab-glioblastoma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/placebo-fibromyalgia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/placebo-schizophrenia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/treatment-a-dyslipidemia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/group-1-10-ug-fmp012-with-2-ug-gla-se-malaria 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/mifamurtide-osteosarcoma 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/dynepo-epoetin-delta-anemia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/dynepo-anemia 2026-06-05 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/stimus-nng-depo-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/asp8374-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/multistem-trauma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/lapaquistat-acetate-dyslipidemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-apoc3-dyslipidemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/acadia-pharmaceuticals-inc/projects/acp-103-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-058-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-063-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-53408-vitiligo 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tl011-dlbcl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-44749-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-cll 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/d-chad63-ca-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/fmp012-with-as01b-adjuvant-system-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/fmp1-as02a-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/gwp42003-p-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/plasmodium-falciparum-malaria-protein-010-fmp010-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/luvadaxistat-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1117568-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis-420915-gsk-299872-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/nabiximols-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ionis-ghr-lrx-acromegaly 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ghr-lrx-acromegaly 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis-fgfr4rx-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aro-inhbe-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/bmn-111-achondroplasia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/bmn-333-achondroplasia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/tg-1801-cll 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/indivior-pharmaceuticals/projects/rbp-7000-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/kailera-therapeutics/projects/kai-7535-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/kailera-therapeutics/projects/kai-9531-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/arcutis-biotherapeutics/projects/arq-252-cream-0-3-vitiligo 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/tyra-biosciences/projects/tyra-300-0-125-mg-kg-achondroplasia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/lakefront-biotherapeutics-nv/projects/glpg3667-dermatomyositis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/pacira-biosciences/projects/exparel-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/413abm-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/mbx-biosciences/projects/mbx-4291-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/maplight-therapeutics/projects/ml-007c-ma-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/cullinan-therapeutics/projects/cln-978-nhl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/kura-oncology/projects/tipifarnib-hnscc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/immunization-with-p-vivax-irradiated-sporozoites-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/motivational-interviewing-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/esperion-therapeutics/projects/etc-1002-dyslipidemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/lb-pharmaceuticals-inc/projects/lb-102-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/zentalis-pharmaceuticals/projects/azenosertib-osteosarcoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/forte-biosciences/projects/fb102-vitiligo 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/zentalis-pharmaceuticals/projects/zn-d5-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/tonix-pharmaceuticals-holding/projects/tnx-102-sl-fibromyalgia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/corbus-pharmaceuticals-holdings/projects/jbt-101-dermatomyositis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/corbus-pharmaceuticals-holdings/projects/lenabasum-20-mg-dermatomyositis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/kazia-therapeutics-ltd/projects/paxalisib-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vtv-therapeutics/projects/ttp435-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/inovio-pharmaceuticals-inc/projects/ino-5401-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/oncolytics-biotech-inc/projects/reolysin-osteosarcoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bioxcel-therapeutics/projects/bxcl501-80-micrograms-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/lisata-therapeutics-inc/projects/certepetide-cholangiocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/phio-pharmaceuticals/projects/dp-cd8-til-hnscc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/akebia-therapeutics/projects/akb-6548-anemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/nmdae-plus-aifa-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/nmdae-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/standard-of-care-imaging-18f-fdg-68ga-psma-or-68-tumor 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/sucrose-iron-subcutaneous-recombinant-human-eryt-anemia 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/immunohistochemistry-or-genetic-test-glioma 2026-06-08 monthly 0.6 https://novapharmanews.com/companies/beam-therapeutics/projects/prdr-glioma 2026-06-08 monthly 0.6